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Objectives The goal of this study was to identify histomorphologic characteristics of atherosclerotic plaques and to determine the
amenability of some of these components to be used as markers for invasive and noninvasive imaging.
Background Rupture of the atherosclerotic plaques is responsible for the majority of acute coronary events, and the culprit
lesions demonstrate distinct histopathologic features. It has been tacitly believed that plaque rupture (PR) is
associated with angiographically minimally occlusive lesions.
Methods We obtained 295 coronary atherosclerotic plaques, including stable (fibroatheroma [FA]; n  105), vulnerable
(thin-cap fibroatheroma [TCFA]; n  88), and disrupted plaques (plaque rupture [PR]; n  102) from the hearts
of 181 men and 32 women who had died suddenly. The hierarchical importance of fibrous cap thickness, per-
cent luminal stenosis, macrophage area, necrotic core area, and calcified plaque area was evaluated by using
recursive partitioning analysis. Because clinical assessment of fibrous cap thickness is not possible by noninva-
sive imaging, it was excluded from the second set of partitioning analysis.
Results Thickness of the fibrous cap emerged as the best discriminator of plaque type; the cap thickness measured
55 m in ruptured plaques, and all FA were associated with 84-m cap thickness. Although the majority of
TCFA were found in the 54- to 84-m thickness group, those with 54-m thickness were more likely to
show 74% luminal stenosis (area under the curve: FA, 1.0; TCFA, 0.89; PR, 0.90). After exclusion of cap
thickness, analysis of the plaque characteristics revealed macrophage infiltration and necrotic core to be
the 2 best discriminators of plaque types (area under the curve: FA, 0.82; TCFA, 0.58; PR, 0.72). More than
75% cross-section area stenosis was seen in 70% of PR and 40% of TCFA; only 5% PR and 10% TCFA were
50% narrowed.
Conclusions This postmortem study defines histomorphologic characteristics of vulnerable plaques, which may help develop
imaging strategies for identification of such plaques in patients at a high risk of sustaining acute coronary
events. (J Am Coll Cardiol 2013;61:1041–51) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.054Acute myocardial infarction or sudden coronary death may
occur as the first manifestation of coronary disease in a large
proportion of otherwise asymptomatic subjects, and the
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2012, accepted October 28, 2012.importance of the identification of subjects at a very high
risk of developing such events cannot be overemphasized.
See page 1052
An acute coronary event has been traditionally considered as
an unavoidable manifestation of coronary atherosclerosis
(1). However, it is becoming increasingly clear that although
the victims of such events often have subclinical disease,
they usually harbor standard risk factors (2). Framingham
risk score has been routinely applied for stratification of
asymptomatic subjects into low-, intermediate-, and high-
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Defining High-Risk Plaques March 12, 2013:1041–51risk categories for the develop-
ment of acute coronary events
(3). Almost 10% of adults in the
United States and Western Eu-
rope belong to the high-risk cat-
egory with an event rate expected
to be 2% per year (3,4). As
recommended in an elegant edi-
torial, such individuals, in addi-
tion to intense global risk factor
reduction, may be better served
by further identification of vul-
nerable plaques in those who are
at very high risk (i.e.,15% acute
coronary events per year) (1). With
the prevention of such events as the
primary goal, the onus is on the
imagers to identify these “accidents
waiting to happen” (2).
Postmortem studies have established plaque rupture (PR)
o be the cause of up to 75% of episodes of acute coronary
yndromes. The disrupted plaques in proximal coronary
rteries usually have a large necrotic core with a thin
verlying fibrous cap (1,5–10); these lesions are substantially
nflamed and have little calcification. It is believed that they
o not cause critical narrowing of the coronary lumen
ecause of outward (expansive or positive) remodeling of the
rterial segment (11–16). It has been proposed that the
esions with similar histomorphologic characteristics but
ntact fibrous caps are vulnerable to rupture. For the current
tudy, we obtained a large number of coronary atheroscle-
otic plaques from the victims of sudden cardiac death to
etermine the importance of various pathological character-
stics (including fibrous cap thickness, percent luminal
tenosis, plaque area, necrotic core area, macrophage area,
nd calcification) in the stable plaques (fibroatheroma [FA]),
Abbreviations
and Acronyms
CT  computed
tomography
EEL  external elastic
lamina
FA  fibroatheroma
FDG  fluorine-18-labeled
2-fluorodeoxyglucose
IEL  internal elastic
lamina
PR  plaque rupture
RPA  recursive
partitioning analysis
TCAP  fibrous cap
thickness
TCFA  thin-cap
fibroatheroma
Figure 1 Gross Morphology of Human Coronary Artery With Dis
(Left) Plaque rupture (PR), showing disruption of fibrous cap at the shoulder regio
ple of thin- cap fibroatheroma (TCFA). A large hemorrhagic necrotic core (NC) is ob
fibrous cap. (Right) Stable plaque. The plaque mainly consists of fibrous tissue wulnerable plaques (thin-cap fibroatheroma [TCFA]), and PR.
e proposed that the hierarchical importance of various
istomorphologic characteristics would allow us to develop
iagnostic strategies for invasive and noninvasive imaging of
ulnerable plaques.
ethods
e evaluated 295 coronary atherosclerotic plaques dissected
rom the hearts of 181 male and 32 female victims of sudden
ardiac death sent to the Cardiovascular Pathology Institute
Gaithersburg, Maryland) for diagnostic consultation from
he medical examiner’s office. All specimens were carefully
erfusion-fixed in 10% buffered formalin for the accurate
easurement of the luminal stenoses. Epicardial arteries
ere then removed from the heart, radiographed, and
rocessed for histopathologic examination (6,16). The left
ain coronary artery, as well as the proximal and middle
egments of the 3 arteries, were examined up to the acute
arginal branch of the right coronary artery, second diag-
nal branch of the left anterior descending, and second
btuse marginal branch of the left circumflex artery. Distal
egments and all branches were excluded from the analysis.
he dissected segments of coronary arteries were serially
ectioned at 3- to 4-mm intervals and processed for histo-
ogical examination. Severely calcified sections recognized
nder radiograph were treated with ethylenediamine-
etraacetic acid (only when decalcification was considered
ecessary). All sections were stained with hematoxylin and
osin, as well as with Movat pentachrome. Atherosclerotic
laques were classified as follows: Vulnerable plaque
TCFA) was defined as the lesion with thin fibrous cap with
nfiltration of macrophages (6,17) and ruptured plaque (PR)
y the presence of acute luminal thrombus with connection
o lipid-rich necrotic core through the disruption of thin
brous cap (Figs. 1 and 2). Stable plaque (FA) was de-
cribed as a plaque with well-matured necrotic core covered by
d, Vulnerable (TCFA), and Stable (FA) Plaques
e plaque (red arrowhead) and thrombus (Thr) superimposed. (Middle) An exam-
within the plaque. White arrows are pointing to the thinnest portion of the
cification (black arrows). FA  fibroatheroma.rupte
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March 12, 2013:1041–51 Defining High-Risk Plaquesthick fibrous cap rich in smooth muscle cell or healed plaque
rupture (i.e., interruption of the fibrous cap with newly formed
thick intimal coverage) (18). TCFA adjacent to PR and FA
djacent to TCFA were excluded so that a longitudinally
istributed plaque may not be repetitively included.
Quantitative morphometry was performed by using com-
uterized planimetry (IPLab, Scanalytics, Inc., Rockville,
aryland). Sections were magnified and digitized, and the
uminal, internal elastic lamina (IEL), and external elastic
amina (EEL) areas were measured. Plaque area was defined as
he difference between IEL and luminal area measurements.
ercent luminal stenosis was calculated as the plaque area/IEL
rea  100. This value is the pathologically defined luminal
tenosis and may not accurately represent an angiographic
ecrease in lumen area. Fibrous cap thickness was measured at
he thinnest part of the fibrous cap or its remnant at the site of
he ruptured plaque. In addition, areas occupied by the necrotic
ore and calcified matrix were assessed in each segment as
reviously described (17,19). Immunohistochemical stains
ere performed for CD68 (KP1 clone; Dako Corporation,
arpinteria, California), and the positive area by using color
hreshold was measured as macrophage infiltration.
tatistical analyses. We evaluated the relationship be-
ween the pathological characteristics and the 3 defined
A B
D E
G H
Figure 2 Photomicrographic Cross-Section of Human Coronary
(A to C) Plaque rupture with mild, moderate, and severe luminal stenosis, respec
occupying the lumen in the image B and C. (D to F) TCFA with mild, moderate, an
not present in the lumen. (G to I) Stable plaque or FA with mild, moderate, and se
present, and calcification (Ca) is frequently seen. Abbreviations as in Figure 1.laque types according to both univariate and multivariable (ethods. Based on the initial evaluation of distributions,
escriptive statistics included mean  SD, as well as medians
and ranges of the pathological features, including fibrous cap
thickness (TCAP), EEL and IEL, plaque and lumen areas,
percent lumen stenosis, necrotic core size, percent necrotic
core, macrophage count per high-power field, percent macro-
phage area, and total and percent calcification area. Preliminary
univariate analyses consisted of applying nonparametric meth-
ods to assess which features initially seemed to provide value in
a final multivariate model. We used the Kruskal-Wallis test for
evaluating differences between plaque types for each of the
features under consideration. In addition, each feature was
evaluated by applying Cunick’s test of trend (20), a nonpara-
metric method based on the assumption of an ordinality of
the plaque categories including FA, TCFA, and PR. Plaque
type was also compared with the traditionally used 3
categories (50%, 50% to 75%, and 75%) of cross-
ectional luminal stenosis and tested with a chi-square test
or independence. Our primary goal was to apply a multi-
ariate method, which, rather than assume and test any a
riori model, would descriptively explore the structure of the
ata with respect to the dominance of individual plaque
haracteristics and combinations of features that may jointly
nfluence plaque rupture. Recursive partitioning analysis
C
F
I
CFA, and FA With Varying Degree of Luminal Stenosis
Nonocclusive Thr is observed in the microphotograph A whereas occlusive Thr is
re luminal stenosis, respectively. NC is covered by a thin fibrous cap, and Thr is
uminal stenosis, respectively. The size of necrotic core is relatively small whenPR, T
tively.
d seve
vere lRPA), also known as classification tree analysis, is well
p
o
s
i measur
us cap
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Defining High-Risk Plaques March 12, 2013:1041–51suited for this purpose. The method is free of distributional
and linearity assumptions, incorporates interactions, and
allows for the re-entry of candidate variables in distinguish-
ing subgroups (21).
RPA was first employed by using TCAP, percent luminal
stenosis and luminal diameter, macrophage area, necrotic
core area, and calcified plaque area as candidate predictor
variables. Because clinical assessment of TCAP is not
amenable to noninvasive imaging, we excluded TCAP in
the second set of RPA.
Each resulting classification tree was evaluated by using a
sample reuse method (training-test subsets) with a 5-fold
cross validation, which resulted in a cross-validated R2. An
overall R2 based on the portion of the log-likelihood
attributed to the model was also included. Each variable’s
contribution to the total resulting chi-square statistic was
also examined. Finally, a receiver-operating characteristic
Descriptive Statistics for Sample CharacteristicsTable 1 Descriptive Statistics for Sample Characteristics
Characteristic
Total (n  295) FA (n  1
Mean  SD Median (range) Mean  SD Me
Age (yrs) 55.1 13.5 53 (29–89) 57.8 14.2 5
TCAP (cap thickness), mm 0.16 0.21 0.05 (0.01–0.96) 0.4 0.19 0.3
EEL area, mm2 13.9 5.8 12.73 (4.6–35.0) 11.6 4.5 10
IEL area, mm2 12.2 5.5 11.16 (3.2–32.4) 10.1 4 9
Lumen area, mm2 3.1 2.4 2.43 (0.09–13.7) 2.5 1.8 2
Plaque area, mm2 9.12 4.5 8.23 (2.6–25.5) 7.6 3.3 7
% Stenosis 75.2 14.5 77.4 (33.0–98.5) 75.8 14.2 76
Necrotic core size, mm2 2.7 3.0 1.74 (0.05–20.5) 1.33 1.0 0.9
% Necrotic core 26.2 8.0 22.0 (1.3–84.8) 17.7 11.5 16
Macrophages, mm2 0.32 0.38 0.17 (0–2.75) 0.12 0.16 0.0
% Macrophages 3.8 4.5 2.1 (0.03–27.4) 1.8 2.4 0
Total calcification, mm2 0.51 0.91 0.035 (0–4.9) 0.46 0.81 0.01
% Calcification 5.5 11.2 0.42 (0–79.0) 6.5 13.5 0.1
Values are for 295 specimens, 250 male, and 45 female. Preliminary evaluations indicated skewn
howed statistically significant differences by plaque type at p  0.01 for all features with the no
n the levels of each feature (p 0.001) with the exception of lumen, percent stenosis, and both
EEL  external elastic lamina; FA  fibroatheroma; IEL  internal elastic lamina; TCAP  fibro
Recursive Partitioning Models ResultsTable 2 Recursive Partitioning Models Results
Model Split Sequence
% Contributio
Total Chi-Squ
All cases (n  295) including TCAP Cap thickness 93.6
% Stenosis 4.4
All cases (n  295) excluding TCAP Macrophages 75.4
Necrotic core 24.6
50%–75% stenosis, excluding TCAP (n  113) Macrophages 86.7
Necrotic core 13.3
75% stenosis, excluding TCAP (n  163) Macrophages 56.7
Necrotic core 35.5
Macrophages 7.8Contribution of major discriminators to total chi-square and calculation of area under the curve (AUC) for the
ROC  receiver-operating characteristic; other abbreviations as in Table 1.curve was generated to quantify the accuracy of the model’s
overall classification ability. RPA was also performed sepa-
rately for 2 subsets of the data based on 50% to 75% and
75% categories of stenosis, with and without inclusion of
TCAP. Less than 50% stenosis was excluded because of the
small sample size (n  19). All analyses were performed by
using JMP version 8.0 (SAS Institute Inc., Cary, North
Carolina), and details of model validation and evaluation
can be found in JMP 8 Statistics and Graphics Guide (22).
Results
Of the 295 coronary atherosclerotic plaques, lesions were
pathologically classified as FA (n 105), TCFA (n  88),
and PR (n 102) (Figs. 1 and 2). Preliminary evaluation of
laque features indicated skewed distributions for continu-
us variables (Table 1), with all tests for normality being
TCFA (n  88) Rupture (n  102)
range) Mean  SD Median (range) Mean  SD Median (range)
89) 56.9 14.0 53 (34–89) 50.7 11.2 47 (29–84)
8–0.96) 0.04 0.02 0.03 (0.01–0.06) 0.03 0.01 0.02 (0.01–0.06)
–33.9) 14 5.9 12.7 (5.2–29.7) 16 6.1 14 (4.7–35)
–28.8) 12.4 5.5 11.3 (4.2–28) 14.2 5.9 13 (3.2–32.4)
–7.9) 3.6 2.4 2.9 (0.1–11.2) 3.2 2.7 2.3 (0.2–13.7)
–22.3) 8.8 4.4 7.8 (2.6–23.5) 11 5 9.8 (2.9–25.5)
6–97.9) 70.8 14.4 70.6 (34.1–98.5) 78.2 14 82 (33–97.6)
5–4.63) 2.26 1.98 1.63 (0.16–9.9) 4.37 4.09 3.08 (0.13–20.46)
–57.9) 25.2 15.7 22.1 (4.4–63.7) 35.9 20.6 32.5 (1.4–84.8)
.86) 0.31 0.36 0.19 (0.01–2.19) 0.53 0.44 0.41 (0.02–2.75)
4.5) 4.1 4.5 2.7 (0.2–23.6) 5.7 5.3 4.1 (0.3–27.4)
.72) 0.50 0.94 0.048 (0–4.91) 0.575 0.993 0.053 (0–4.94)
9.0) 5.3 11.43 0.67 (0–75.6) 4.77 7.67 0.54 (0–35.43)
plaque feature distributions, with all tests for normality rejected at p 0.001. Kruskal-Wallis tests
ception of both total and percent calcification. Trend test indicated statistically significant trends
es of calcification.
thickness; TCFA  thin-cap fibroatheroma.
R2 ROC, AUC
Overall
5-Fold Cross-
Validation FA (n  105) TCFA (n  88) RP (n  102)
0.678 0.665 1.00 0.888 0.897
0.214 0.197 0.82 0.576 0.774
0.249 0.202 0.813 0.698 0.848
0.26 0.206 0.864 0.585 0.81705)
dian (
5 (34–
7 (0.0
.6 (4.6
.4 (4.2
.2 (0.1
.6 (2.6
.9 (43.
6 (0.0
.3 (1.3
7 (0–0
.9 (0–1
4 (0–3
9 (0–7
ess for
table exn to
arediagnostic accuracy.
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March 12, 2013:1041–51 Defining High-Risk Plaquesrejected at p  0.001. Kruskal-Wallis tests showed statis-
tically significant differences according to plaque type (at
p  0.01 level) for all features, with the exception of total
nd percent calcification. Trend test indicated statistically
ignificant trends in the levels of each characteristic (p 
.001), with the exception of percent lumen stenosis and
oth measures of calcification. Distributions of categories of
tenosis within plaque type varied, as shown by the chi-
quare test (p  0.0004) (Table 2).
nalysis of plaque characteristics. Analysis of 102 PR
ound 75% cross-section area stenosis in 70% of instances
nd 50% to 75% stenosis in 25% of the ruptured plaques;
nly 5% of the PR had 50% cross-section area stenosis
Figs. 2 and 3). Conversely, 40% of the 88 TCFA showed
75% cross-sectional area stenosis, and 50% of TCFA
howed stenosis of 50% to 75%; 10% of the TCFA had
50% cross-section area stenosis. The difference in distri-
A
B
Figure 3 Luminal Obstruction in FA, TCFA, and PR
(A) Bar graph and (B) boxplot show 50% cross-sectional vascular area stenosis
before plaque rupture. Boxplot shows numerical data through the lower quartile, m
ple maximum observations. Abbreviations as in Figure 1.ution of the extent of stenosis in TCFA and PR (obtained
rom different deceased subjects) may suggest that the
laques that rupture are substantially narrowed at the time
f the acute event, and it is rare to find disrupted but
onstenotic plaques (Fig. 3).
RPA allowed us to identify the morphological charac-
eristics in hierarchical importance that segregated PR,
CFA, and PR (Figs. 4 and 5). For the multivariable
PA model, which included all cases and all candidate
ariables, TCAP emerged as the dominant plaque char-
cteristic in its ability to discriminate between 3 plaque
ypes. TCAP thickness was always 84 m in FA (Fig. 4)
(Table 2); the plaques that were 84 m at their thinnest
diameter included almost all TCFA and PR. Further
partitioning revealed that the fibrous caps associated with
PR measured 54 m at the site of rupture. Therefore, the
plaques covered by 84-m TCAP were stable, and PR
ajority of PR and TCFA. The distribution indicates that TCFA may further enlarge
, and upper quartile, and the whiskers represent the sample minimum and sam-in a m
edian
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Defining High-Risk Plaques March 12, 2013:1041–51demonstrated fibrous cap attenuation to54 m. Although
the majority of TCFA were found in the 54- to 84-m
hickness group, a subset of TCFA showed 54-m
CAP. By the next step of RPA, those TCFA plaques that
emonstrated 54-m cap thickness (and had not yet
isrupted) were more likely to show 74% cross-section
rea stenosis. This finding allows us to support the
STEP 1
STEP 2
STEP 3
Figure 4 Multivariate RPA Model Including All Cases and All C
Cap thickness was the key plaque characteristic in its ability to discriminate betwe
84 m. TCAP in PR measured 54 m (red). Blue represents TCFA. The receiv
area under the curve: FA, 0.82; TCFA, 0.58; and PR, 0.72. G^2 statistic is a likeli
in the partitioning process. Similar to the Pearson chi-square test (and asymptotic
samples and for nested models. RPA  recursive partitioning analysis; other abbrontention that vulnerable plaques will need to encroach barther on the lumen and demonstrate critical fibrous cap
hinning before an actual event. This signifies the impor-
ance of a combination of TCAP and luminal stenosis as
he best measure for identifying the natural history of
laques.
PA after exclusion of TCAP. Because TCAP is only
menable to invasive imaging methods and thus would not
ate Variables
3 plaque types, with all stable FA (green) separated into a subgroup of
ating characteristic curve generated from the analysis suggested the following
atio chi-square test on which the candidate variables are evaluated for inclusion
ual), G^2 is a goodness-of-fit test and considered more appropriate for smaller
ns as in Figure 1.andid
en the
er-oper
hood-r
ally eq
eviatioe clinically practical for screening asymptomatic subjects,
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March 12, 2013:1041–51 Defining High-Risk Plaqueswe repeated the RPA excluding TCAP from analysis (Fig. 4,
Table 2). The segregation of the 3 types of plaques was not
as clear as it was when TCAP was included. Of the
Figure 5 Multivariate RPA Model Including All Cases But Exclu
Predominance of macrophage infiltration identified a majority of PR (red) and TCFA
larger NC. The few remaining less inflamed and small core PR and TCFA could be is
characteristic curve generated from the analysis suggested the following area
were observed in re-analysis including only the lesions showing 50% to 75% lu
0.85. The results were similar for those with 75% diameter stenosis; area un
and 4.remaining plaque characteristics, plaque inflammation al-lowed separation of PR and TCFA from FA. The discrim-
inatory level of inflammation was 0.21 mm2 macrophage
area per high-power microscopic field area. Although most
STEP 1
STEP 2
STEP 3
Cap Thickness as the Candidate Variable
). TCFA and PR in the less-inflamed group (contaminating the FA group) showed
from FA (green) once again by the degree of inflammation. The receiver-operating
the curve: FA, 0.82; TCFA, 0.58; and PR, 0.72. Essentially, similar results
diameter stenosis; area under the curve: FA, 0.81; TCFA, 0.70; and PR,
e curve: FA, 0.86; TCFA, 0.59; and PR, 0.82. Abbreviations as in Figures 1ding
(blue
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der thof FA demonstrated lack of substantial inflammation, a
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Defining High-Risk Plaques March 12, 2013:1041–51small proportion of PR and TCFA segregated with the
group of less than the discriminatory level of inflamma-
tion. Less inflamed PR and TCFA could be separated
from FA by the simultaneous presence of a necrotic core
area 3.5 mm2. A minority of TCFA remained in the
ess inflamed and small necrotic core group with FA, and
laque inflammation once again allowed further separa-
ion of FA in the third step of RPA. It seems logical to
ropose that inflamed plaques and large necrotic cores are
key features of plaque vulnerability when TCAP is not
vailable.
iscussion
he current study suggests that TCAP, whenever available,
ffers the best discriminator of a vulnerable plaque (Table 2).
he54-m cap thickness in PR is similar to the thickness
reported clinically by using optical coherence tomography
interrogation of culprit lesions in patients presenting with
acute coronary events (23,24). This investigation also reveals
that the fibrous caps are thicker than 84 m in plaques
earing the pathological features of stable plaques. Most
CFA fall in the 54- to 84-m range. Some TCFA, which
demonstrate 54-m TCAP, are usually associated with
74% luminal stenosis. It seems logical to propose that
hen intravascular imaging information is available, the
esions with 85-m thick cap (rounding the figure to the
earest multiple of 5) and 75% cross-sectional luminal
rea stenosis should alert the clinicians. This pathological
tudy confirms the results of the recent prospective natural
istory study of plaque vulnerability PROSPECT (Provid-
ng Regional Observations to Study Predictors of Events in
he Coronary Tree), wherein the greater plaque burden
70%), smaller luminal diameter (4 mm2), and intravas-
cular ultrasound–based TCFA were associated with adverse
outcomes during a 3.4-year follow-up (25). The plaque
burden (area) did not emerge as a significant determinant of
plaque vulnerability in our study, and it seems logical to
propose that precise information about TCAP with the
degree of luminal stenosis may overshadow the impor-
tance of plaque burden. It also seems logical to believe
that a thin cap with luminally obstructive lesion would be
associated with large plaque burden predominantly aris-
ing from inflamed and necrotic core–rich morphology.
Further investigation, similar to PROSPECT, is war-
ranted to clinically confirm the importance of TCAP in
luminally stenotic lesions; optical coherence tomography
with a resolution of 10 m may allow better definition
of TCAP (23,24,26).
The luminal stenosis loses its importance as the predictor
of a vulnerable plaque when TCAP is not available as a
candidate variable, and morphological characterization of
plaque becomes important to demonstrate the magnitude of
plaque inflammation and the necrotic cores. Strategies for
the noninvasive assessment of these 2 plaque features willtherefore need to be developed. Necrotic cores have been
identified as low-attenuation plaque areas (30 HU) on
coronary CT angiography imaging, which are frequently
associated with expansive remodeling (110%) of the af-
fected coronary segments (27–29). CT angiography is also
able to demonstrate the extent of luminal stenosis with
reasonable accuracy (30). Positively remodeled low-
ttenuation plaques as identified by using CT angiography
ere associated with a 22.5% adverse event rate over a
-year follow-up period, compared with 0.5% in the
bsence of these plaque characteristics (29). The low-
ttenuation plaque (and volume) was larger and the extent
f remodeling greater in the plaques that subsequently
eveloped an acute event (Table 3). Furthermore, the
reater the remodeling index and the larger the necrotic core
ize, the earlier the acute coronary event occurred in
ollow-up. The positively remodeled plaques on CT angiog-
aphy showing the necrotic core area of 0.5 mm2 did not
esult in acute coronary syndrome. Unlike the feasibility of
ecrotic core size assessment, there is as yet no available
linical method to accurately assess degree of plaque inflam-
ation. Although increased circulating levels of inflamma-
ory biomarkers (e.g., high-sensitivity C-reactive protein)
ortend unfavorable outcomes, no postmortem study has yet
eported its relationship with the extent of macrophage
nflammation in the culprit atherosclerotic lesions (31,32).
t has recently been proposed that the extent of
acrophage-based inflammation in plaques can be identi-
ed by combined CT angiography and positron emission
omography imaging employing fluorine-18 –labeled
-fluorodeoxyglucose (FDG) (33–35).
FDG-based positron emission tomography in carotid
arteries has been correlated with the extent of macrophage
infiltration in carotid endarterectomy specimens and is more
often associated with symptomatic disease (36–38). Al-
though anecdotal reports of FDG uptake in coronary
plaques were available (39,40), a recent study has reported
FDG uptake in culprit lesions in patients presenting with
acute coronary events and a lack thereof in lesions in
patients presenting with stable coronary syndromes (33).
Such an imaging strategy would need considerable improve-
ment because it currently requires restricting myocardial
FDG uptake for sufficient contrast resolution by feeding a
high-fat diet to the patients (33,34).
The current study also offers intriguing insights into
plaque biology. Whereas two-thirds of the PR demon-
strated 75% cross-section area narrowing (Fig. 3), the
majority of TCFA showed 50% to 75% luminal narrowing.
We therefore extrapolate that the TCFA may need to
expand or grow bigger before they rupture. Alternatively, it
can be explained that among many of the potentially
vulnerable plaques, only the few that are severely stenotic
eventually rupture. However, the angiography report in
which the information about angiographic stenosis was
available at the time of an acute coronary event and also 1
year earlier (41) supports the progression of plaques before
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the extent of luminal compromise increased significantly
during the period of observation. The PROSPECT study
also prospectively confirmed that the mean angiographic
diameter stenosis of the 106 lesions subsequently responsi-
ble for major adverse cardiovascular events was 32  21% at
baseline and 65  16% at 3.4-year follow-up (p  0.001)
(25). The amenability of luminally occlusive lesions for
plaque rupture is not contradictory to the belief that the
fateful plaques responsible for acute coronary events are
more likely to be mildly obstructive (11–13). This assump-
tion of the association of 50% luminal obstruction with
culprit lesions has been based primarily on reports in which
the previous coronary angiograms happened to be available
for a review. As discussed earlier, the availability of serial
angiograms confirms the interval progression in the luminal
stenosis before the occurrence of a coronary event (25,41).
In addition, noninvasive stress tests using radionuclide and
ultrasound imaging have revealed significant prognostic
value of the inducible ischemia for predicting major adverse
cardiac events (42–45), alluding to the prognostic signifi-
cance of flow-limiting coronary lesions. More recent studies
using CT angiography and magnetic resonance imaging
have produced similar results for all ages and both sexes
(46–50).
Relatively rapid increase in plaque volume reportedly
results from intraplaque hemorrhage in acute carotid events
(51) and is almost always seen before the event (52). A
similar role for plaque hemorrhage has been proposed for
acute coronary events (53,54). However, although erythro-
cyte extravasation is observed to a variable extent in coronary
plaques (29,31) and is known to correlate with the magni-
tude of necrotic core size, intraplaque hemorrhages are less
common than carotid vasculature. Another possible mech-
anism could involve the plaque attaining the Glagovian
limit of positive remodeling; it is plausible that failing to
further expand outward, the plaque encroaches on the
lumen (16). Most importantly, the repeated plaque rup-
ture and healing cycles are very common in coronary
arteries and contribute substantially to plaque growth; the
greater the number of previous ruptures, the larger the
plaque volume (55). It is logical to presume that a thinner
cap of significantly stenotic lesions would be more
amenable to mechanical rupture and an acute event in
response to hemodynamic perturbations. Conversely, the
less stenotic TCFA may hypothetically be more amenable
to rupture-healing cycles.
Study limitations. First, there was a lack of clinical infor-
mation in these patients and firm data regarding whether
the vessel was an infarct-related artery. The study specimens
were sent to us from the medical examiner=s office, wherein
not much clinical information is usually available. There-
fore, although these plaques were carefully analyzed, there
was no information on the real culprit lesion in many of
these patients. Second, although this study included plaque
area as an important histological parameter, informationabout the positive remodeling was lacking; this would have
required pathological characterization of the entire vascular
length. Third, all parameters were acquired in a cross-
section and not from the longitudinal study of the plaque.
Therefore, the necrotic core size was defined wherever the
minimum luminal diameter was seen and the thinnest
TCAP was measured in the same section. Unlike the
pathological studies, the intravascular imaging technology
and coronary CT angiography reports have the advantage of
describing the disease both at the cross-sectional level (in
terms of area calculation) and by the analysis of entire
plaque longitudinally (for the volume calculation). Fourth,
the role of intraplaque hemorrhage was not independently
addressed, and the area of hemorrhage was included within
the necrotic core area. Fifth, the use of autopsy data may not
be representative of plaque morphology in patients who
have coronary artery disease and survive. Finally, this study
only addressed the plaque rupture and its precursor as the
substrate for acute coronary syndrome and does not include
the culprit plaques characterized by endothelial erosion
responsible for up to one-third of acute coronary events
(6,56).
Conclusions
This postmortem study defines histomorphologic character-
istics of vulnerable plaques, which may help development of
invasive and noninvasive imaging strategies for identifica-
tion of such lesions in patients at a high risk of sustaining
acute coronary events. Although this study offers measurable
indicators of plaque vulnerability, better tools for preselec-
tion of high-risk patients will need to be identified
because the available noninvasive imaging procedures
inflict nonnegligible levels of radiation burden. Con-
versely, invasive characterization of high-risk patients,
although not feasible on a large-scale basis, seems to have
distinct advantages in terms of being able to measure
more accurately more powerful classifiers of risk such as
TCAP and may find a place in decision making during
coronary interventions.
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